Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ZhongTing Zhang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Nano|December 3, 2024
Simultaneously Enhanced Damping and Stiffness of Amorphous DiaphiteZhongTing Zhang, HengAn Wu, YinBo Zhu
National Science Review|March 20, 2024
Discontinuous phase diagram of amorphous carbonsYinBo Zhu, ZhouYu Fang, ZhongTing Zhang, et al.
Nano Letters|December 22, 2023
Temperature-Dependent Paracrystalline Nucleation in Atomically Disordered DiamondsZhongTing Zhang, ZhouYu Fang, HengAn Wu, et al.
ACS Nano|March 27, 2026
Density-Driven to Phonon-Dominated: Crossover in Heat Capacity of Amorphous CarbonsKe Li, ZhongTing Zhang, ZhengYue Lin, et al.
Journal for Immunotherapy of Cancer|June 19, 2019
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profileQingnan Zhao, Jiemiao Hu, Abhisek Mitra, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumorsJiemiao Hu, Qing Yang, Wendong Zhang, et al.
Pediatric Blood & Cancer|July 25, 2020
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortiumJonathan Gill, Wendong Zhang, Zhongting Zhang, et al.
Molecular Cancer Therapeutics|June 3, 2022
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing ConsortiumPooja Hingorani, Wendong Zhang, Zhongting Zhang, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Nano|December 3, 2024
Simultaneously Enhanced Damping and Stiffness of Amorphous DiaphiteZhongTing Zhang, HengAn Wu, YinBo Zhu
National Science Review|March 20, 2024
Discontinuous phase diagram of amorphous carbonsYinBo Zhu, ZhouYu Fang, ZhongTing Zhang, et al.
Nano Letters|December 22, 2023
Temperature-Dependent Paracrystalline Nucleation in Atomically Disordered DiamondsZhongTing Zhang, ZhouYu Fang, HengAn Wu, et al.
ACS Nano|March 27, 2026
Density-Driven to Phonon-Dominated: Crossover in Heat Capacity of Amorphous CarbonsKe Li, ZhongTing Zhang, ZhengYue Lin, et al.
Journal for Immunotherapy of Cancer|June 19, 2019
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profileQingnan Zhao, Jiemiao Hu, Abhisek Mitra, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumorsJiemiao Hu, Qing Yang, Wendong Zhang, et al.
Pediatric Blood & Cancer|July 25, 2020
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortiumJonathan Gill, Wendong Zhang, Zhongting Zhang, et al.
Molecular Cancer Therapeutics|June 3, 2022
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing ConsortiumPooja Hingorani, Wendong Zhang, Zhongting Zhang, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
Molecular Cancer Therapeutics|January 10, 2026
Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma ModelsYifei Wang, Zhongting Zhang, Caterina Longo, et al.
Pageof 2